https://journals.lww.com/journaladdictionmedicine/Abstract/publishahead/Self_reported_Health_Diagnoses_and_Demographic.99327.aspx

Comment; Bottom line? Kratom seems to work better at easing transition from drug dependency and those who self-medicate mental illness report better satisfaction than those who try to get relief from acute and/or chronic pain disorders. Alcohol is the most widely used pain killer for a simple reason–easiest availability. Kratom’s not the best choice for ANY of the above issues–but can be had without a prescription–so it’s more likely to be tried for a variety of issues.

Bath, Rhiannon; Bucholz, Tanner; Buros, Amy F. PhD; Singh, Darshan PhD; Smith, Kirsten E. MS; Veltri, Charles A. PhD; Grundmann, Oliver PhDJournal of Addiction Medicine: September 17, 2019 – Volume Publish Ahead of Print – Issue – pdoi: 10.1097/ADM.0000000000000570Original Research: PDF OnlyBUYPAP

Objectives: To determine whether diagnosed pre-existing health conditions correlate with Kratom demographics and use patterns.

Methods: A cross-sectional, anonymous US national online survey was conducted among 8049 Kratom users in October, 2016 to obtain demographic, health, and Kratom use pattern information.

Results: People who use Kratom to mitigate illicit drug dependence self-reported less pain and better overall health than individuals who used Kratom for acute/chronic pain. Self-reported improvements in pre-existing mental health symptoms (attention deficit and hyperactivity disorder/attention deficit disorder, anxiety, bipolar disorder, post-traumatic stress disorder, and depression) attributed to Kratom use were greater than those related to somatic symptoms (back pain, rheumatoid arthritis, acute pain, chronic pain, fibromyalgia). Demographic variables, including female sex, older age, employment status, and insurance coverage correlated with increased likelihood of Kratom use.

Conclusions: Kratom use may serve as a self-treatment strategy for a diverse population of patients with pre-existing health diagnoses. Healthcare providers need to be engaging with patients to address safety concerns and potential limitations of its use in clinical practice for specific health conditions.

Dr. Raymond Oenbrink